ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

LUANA CARCASSONI M.D.

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,094Medicare Part D Prescriptions Filled, Including Refills

Rank: 225 out of 3593

$617K Total Retail Price of All Prescriptions

Rank: 412 out of 3593

467 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
80% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

10% of this provider’s 467 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 15,089 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$38 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 867 816 1 1
OMEPRAZOLE 711 680 2 5
LEVOTHYROXINE SODIUM 539 500 3 4
AMLODIPINE BESYLATE 515 512 4 3
LISINOPRIL 451 413 5 2
METFORMIN HCL 402 377 6 6
VOLTAREN 383 372 7 85
CLONIDINE HCL 345 334 8 41
HYDROCHLOROTHIAZIDE 335 324 9 10
METOPROLOL TARTRATE 324 305 10 8
CRESTOR 321 311 11 21
ATORVASTATIN CALCIUM 310 284 12 15
BENICAR 285 265 13 131
DIOVAN 263 263 14 46
ATENOLOL 255 242 15 11
ACTONEL 252 242 16 197
GLIPIZIDE XL 231 218 17 179
RANITIDINE HCL 225 225 18 27
BENICAR HCT 218 207 19 155
VIAGRA 212 203 20 84
CLOPIDOGREL 188 172 21 30
ZOLPIDEM TARTRATE 187 180 22 12
AMLODIPINE BESYLATE-BENAZEPRIL 187 181 22 65
FAMOTIDINE 187 165 22 70
PENTOXIFYLLINE 178 178 25 149
LANSOPRAZOLE 173 173 26 113
ALPRAZOLAM 167 163 27 37
CLOTRIMAZOLE-BETAMETHASONE 164 143 28 94
DICYCLOMINE HCL 156 130 29 190
ENALAPRIL MALEATE 156 153 29 38
FUROSEMIDE 145 117 31 9
CARVEDILOL 139 138 32 23
DIOVAN HCT 136 121 33 76
SYNTHROID 130 113 34 51
LACTULOSE 126 112 35 126
PANTOPRAZOLE SODIUM 124 99 36 45
VESICARE 118 118 37 205
TEMAZEPAM 116 111 38 56
FOLIC ACID 115 115 39 117
PLAVIX 113 103 40 42
FLUTICASONE PROPIONATE 112 109 41 32
BYSTOLIC 111 104 42 182
NAMENDA 111 111 42 50
IBUPROFEN 110 85 44 43
DOXAZOSIN MESYLATE 105 83 45 63
POTASSIUM CHLORIDE 101 89 46 24
SINGULAIR 101 78 46 77
ADVAIR DISKUS 97 78 48 47
WARFARIN SODIUM 97 97 48 18
VENTOLIN HFA 96 81 50 80
GABAPENTIN 89 82 51 16
ALLOPURINOL 89 86 51 35
TRAMADOL HCL-ACETAMINOPHEN 86 73 53 147
NEXIUM 85 82 54 36
MECLIZINE HCL 84 83 55 96
ESCITALOPRAM OXALATE 80 80 56 71
AZITHROMYCIN 79 75 57 34
GLYBURIDE-METFORMIN HCL 77 77 R 58 95
TRAMADOL HCL 76 65 59 17
CYCLOBENZAPRINE HCL 76 73 R 59 72
GLIMEPIRIDE 75 75 61 44
CLOBETASOL PROPIONATE 74 72 62 187
GALANTAMINE HBR 71 71 63 239
ALENDRONATE SODIUM 70 70 64 22
LOSARTAN POTASSIUM 70 65 64 14
FENOFIBRATE 67 67 66 39
SERTRALINE HCL 66 56 67 28
HYDROCODONE-HOMATROPINE MBR 66 61 S3 10 67 555
CLONAZEPAM 65 54 69 164
NAPROXEN 64 64 70 68
ISOSORBIDE MONONITRATE ER 63 63 71 61
FINASTERIDE 62 62 72 79
TAMSULOSIN HCL 61 60 73 33
ALBUTEROL SULFATE 61 59 73 157
LANTUS 59 59 75 57
METOPROLOL SUCCINATE 58 53 76 19
GEMFIBROZIL 54 54 77 88
LISINOPRIL-HYDROCHLOROTHIAZIDE 54 35 77 26
AVODART 53 53 79 180
AMMONIUM LACTATE 52 40 80 125
MONTELUKAST SODIUM 51 37 81 151
VALSARTAN-HYDROCHLOROTHIAZIDE 51 46 81 412
LOVASTATIN 50 38 83 20
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.